These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13234939)

  • 41. How to Treat Essential Thrombocythemia and Polycythemia Vera.
    Besses C; Alvarez-Larrán A
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S114-23. PubMed ID: 27521307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based management of polycythemia vera.
    Barbui T; Finazzi G
    Best Pract Res Clin Haematol; 2006; 19(3):483-93. PubMed ID: 16781485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polycythemia vera associated with lymphomatous diseases and myeloma.
    Heinle EW; Sarasti HO; Garcia D; Kenny JJ; Westerman MP
    Arch Intern Med; 1966 Oct; 118(4):351-5. PubMed ID: 5925233
    [No Abstract]   [Full Text] [Related]  

  • 44. Elevated plasma beta-thromboglobulin levels in multiple myeloma and in polycythaemia vera.
    Schernthaner G; Ludwig H; Silberbauer K
    Acta Haematol; 1979; 62(4):219-22. PubMed ID: 93844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ERYTHREMIA (polycythemia vera), radiation therapy, and leukemia.
    J Am Med Assoc; 1959 Jan; 169(2):136-42. PubMed ID: 13610645
    [No Abstract]   [Full Text] [Related]  

  • 46. [THE FIBRIN STABILIZING FACTOR OF LAKI AND LORAND IN HISTIOCYTIC SARCOMATOSES WITH SYSTEMIC TENDENCY].
    OTTAVIANI P; MANDELLI F; FONTANA L; MORELLI R
    Prog Med (Napoli); 1965 Jan; 21():10-3. PubMed ID: 14346632
    [No Abstract]   [Full Text] [Related]  

  • 47. [Myleran therapy of erythrocythemia vera].
    KIRCHMAYER S; SZARBINSKI T
    Pol Tyg Lek; 1961 Jan; 16():173-6. PubMed ID: 13756210
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical update in polycythemia vera and essential thrombocythemia.
    Tefferi A; Solberg LA; Silverstein MN
    Am J Med; 2000 Aug; 109(2):141-9. PubMed ID: 10967156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of polycythemia vera.
    Wasserman LR
    Semin Hematol; 1976 Jan; 13(1):57-78. PubMed ID: 1251223
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of therapy on causes of death in polycythemia vera.
    Wasserman LR; Balcerzak SP; Berk PD; Berlin NI; Donovan PB; Dresch C; Ellis JT; Goldberg JD; Landaw SA; Laszlo J; McIntyre OR; Najean Y; Pisciotta AV; Silverstein MN; Tartaglia AP; Tatarsky I; Weinfeld A
    Trans Assoc Am Physicians; 1981; 94():30-8. PubMed ID: 7344226
    [No Abstract]   [Full Text] [Related]  

  • 53. [New method of the treatment of polycythemia vera; transfusion of plasma from young donors in substitution for blood and plasma extract].
    CORELLI F; MARINOSCI A
    Prog Med (Napoli); 1952 Jun; 8(12):355-63. PubMed ID: 12983422
    [No Abstract]   [Full Text] [Related]  

  • 54. A cooperative study of polycythemia vera.
    Wasserman LR
    Ann N Y Acad Sci; 1985; 459():328-33. PubMed ID: 3868329
    [No Abstract]   [Full Text] [Related]  

  • 55. The cellular elements of the blood.
    REICH C
    Clin Symp; 1962; 14():79-109. PubMed ID: 13973706
    [No Abstract]   [Full Text] [Related]  

  • 56. [The value of the leukocytic alkaline phosphatase index in normal and pathological states].
    NICOLAU CT; NICOARA ST; VERMONT I; GIORGIU T; EUGENIU A
    Med Interna (Bucur); 1962 Oct; 14():1173-81. PubMed ID: 13938401
    [No Abstract]   [Full Text] [Related]  

  • 57. Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.
    Barbui T; Passamonti F; Accorsi P; Pane F; Vannucchi AM; Velati C; Gale RP; Tura S; Barosi G
    Leukemia; 2018 Sep; 32(9):2077-2081. PubMed ID: 29955128
    [No Abstract]   [Full Text] [Related]  

  • 58. The management of polycythaemia vera.
    Wasserman LR
    Br J Haematol; 1971 Oct; 21(4):371-6. PubMed ID: 4941523
    [No Abstract]   [Full Text] [Related]  

  • 59. Some clinical experience in the use of triethylene melamine (TEM).
    HAMERMAN DJ; MELAMED S
    J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
    [No Abstract]   [Full Text] [Related]  

  • 60. Erythrocytosis due to presumed polycythemia vera.
    Patell R; Theil K; Lichtin A
    Cleve Clin J Med; 2016 Sep; 83(9):648-53. PubMed ID: 27618352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.